2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theMitral Valve Disease Market?

The mitral valve disease market is predicted to grow due to the escalating occurrence of vascular heart diseases. The umbrella term “vascular heart diseases” refers to conditions impacting the blood vessels within the heart or those that supply the heart. The spike in these heart diseases can be attributed to a complex conjunction of lifestyle decisions, demographic shifts, medical conditions, environmental influences, and genetic factors. Vascular heart diseases, including ischemic heart disease and hypertension, may indirectly lead to mitral valve disease by affecting the structure and functionality of the heart. For instance, data from the 2020-21 National Health Survey conducted by the Australian Institute of Health and Welfare, a government agency, reveals that the mortality rate due to cardiovascular disease in Australia surged from 143.7 per 100,000 population in 2021 to 148.2 in 2022 amongst males. Thus, the mitral valve disease market is being propelled by the rising prevalence of vascular heart diseases.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16480&type=smp

#What is the Growth Potential of the Mitral Valve Disease Market, and How Will It Perform by 2034?

The market size for mitral valve disease has seen substantial growth in the past few years. There is an anticipated growth from $3 billion in 2024 to $3.3 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. Factors driving this growth in the historical period include initiatives for patient education, suitable reimbursement policies and insurance coverage, increasing healthcare spending, heightened awareness and screening efforts, and a growing market presence.

The market size for mitral valve disease is predicted to witness a robust growth in the coming years, increasing to a staggering $4.73 billion by 2029 with a compound annual growth rate (CAGR) of 9.4%. This expansion during the projected period can be credited to the growing instances of mitral valve disease, rising favor towards minimally invasive procedures, the surge in innovations related to heart valve surgeries, escalating venture capital investments, and the growing interest among manufacturers. Significant trends predicted for the forecast period encompasses advancements in technology, progress in transcatheter technologies, and a surge in the technological advancements pertaining to surgical procedures.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16480

What Key Market Trends and Innovations Are Shaping the Future of theMitral Valve Disease Industry?

Leading organizations in the mitral valve disease market are introducing stented tissue valves as a response to increasing patient preference for less invasive treatment methods. These valves are developed to provide dependable and durable performance, presenting a substitute to traditional surgical procedures. For example, Medtronic, a healthcare corporation based in Ireland, in April 2024, released the Avalus Ultra valve. This advanced surgical aortic tissue valve is built for improved user experience during implantation and for managing patients over an extended period. Learning from ten years of hands-on clinical experience with the initial Avalus valve, the new Avalus Ultra comes equipped with a low valve profile for easy implantation, a PEEK base frame for maintaining uniform roundness, and an Effective Orifice Area (EOA) that excels in the industry and potentially enhances blood flow. Furthermore, it is comprised of a radiopaque coil for unambiguous visibility in potential future valve-in-valve procedures.

Which Companies Are Leading the Charge in Expanding theMitral Valve Disease Market Growth?

Major companies operating in the mitral valve disease market are Pfizer Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc., Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve Technology Inc., 4C Medical technologies, Labcor Laboratorios Ltda, CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro International Devices Inc., Neovasc Inc., Mitralign Inc., Transcatheter Technologies GmbH

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report

How is the Global Mitral Valve Disease Market Segemented?

The mitral valve disease market covered in this report is segmented –

1) By Treatment Type: Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy, Mitral Valve Therapeutics

2) By Indication: Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Mitral Valve Repair: Surgical Repair, Minimally Invasive Repair, Percutaneous Mitral Valve Repair

2) By Mitral Valve Replacement: Mechanical Valve Replacement, Biological Valve Replacement, Transcatheter Mitral Valve Replacement (TMVR)

3) By Cardiac Resynchronization Therapy: Pacemaker Therapy, Implantable Cardioverter-Defibrillators (ICD), Biventricular Pacing

4) By Mitral Valve Therapeutics: Pharmacological Treatments, Anticoagulation Therapy, Mitral Valve Repair Devices

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=16480&type=smp

Which Geographics are Influencing the Growth of the Mitral Valve Disease Market?

Europe was the largest region in the mitral valve disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Mitral Valve Disease Market 2025, By The Business Research Company:

Pigging Valves Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pigging-valves-global-market-report

Aerospace Valves Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/aerospace-valves-global-market-report

Hygienic Pumps And Valves Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hygienic-pumps-and-valves-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: